Brain tumors are complex and relatively rare. For many pathologists and community hospitals, less than 5% of their surgical pathology cases include patients with brain tumors. Our second-opinion consultations give neuropathologists access to Mayo Clinic neuropathologists who can help choose the most appropriate molecular and cytogenetic testing. Our experts help integrate laboratory results with clinical and histopathological information for a comprehensive report with patient-specific diagnostic, prognostic, and therapeutic information.
PATHC | Pathology Consultation
Neuro-oncology informative cases
Clinical studies at Mayo Clinic have shown that this broad but tumor-specific genetic analysis has significant — and sometimes unexpected — clinical impact. The following case studies highlight the importance and clinical utility of these assays in diagnosis, prognosis, and therapy selection.